Alnylam Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights Recent Period Activity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Alnylam Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights Recent Period Activity

Alnylam Pharma (ALNY) Tops Q3 EPS by 54c

October 31, 2019 8:01 AM EDT

Alnylam Pharma (NASDAQ: ALNY) reported Q3 EPS of ($1.50), $0.54 better than the analyst estimate of ($2.04). Revenue for the quarter came in at $70.1 million versus the consensus estimate of $56.41 million.

2019 Financial Guidance:

Alnylam reiterates its expectations for 2019 non-GAAP R&D... More